Logo image of LNTH

LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis

NASDAQ:LNTH - US5165441032 - Common Stock

56.555 USD
-1.66 (-2.84%)
Last: 8/25/2025, 11:13:04 AM
Fundamental Rating

7

Overall LNTH gets a fundamental rating of 7 out of 10. We evaluated LNTH against 185 industry peers in the Health Care Equipment & Supplies industry. LNTH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LNTH scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make LNTH a good candidate for value and quality investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

LNTH had positive earnings in the past year.
LNTH had a positive operating cash flow in the past year.
In multiple years LNTH reported negative net income over the last 5 years.
In the past 5 years LNTH always reported a positive cash flow from operatings.
LNTH Yearly Net Income VS EBIT VS OCF VS FCFLNTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

LNTH's Return On Assets of 12.81% is amongst the best of the industry. LNTH outperforms 94.05% of its industry peers.
Looking at the Return On Equity, with a value of 23.23%, LNTH belongs to the top of the industry, outperforming 95.68% of the companies in the same industry.
The Return On Invested Capital of LNTH (18.03%) is better than 96.76% of its industry peers.
LNTH had an Average Return On Invested Capital over the past 3 years of 16.25%. This is significantly above the industry average of 8.44%.
The 3 year average ROIC (16.25%) for LNTH is below the current ROIC(18.03%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.81%
ROE 23.23%
ROIC 18.03%
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
LNTH Yearly ROA, ROE, ROICLNTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

1.3 Margins

LNTH has a better Profit Margin (17.82%) than 92.97% of its industry peers.
LNTH's Profit Margin has improved in the last couple of years.
The Operating Margin of LNTH (28.64%) is better than 95.68% of its industry peers.
In the last couple of years the Operating Margin of LNTH has grown nicely.
With a decent Gross Margin value of 63.75%, LNTH is doing good in the industry, outperforming 65.41% of the companies in the same industry.
LNTH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 28.64%
PM (TTM) 17.82%
GM 63.75%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
LNTH Yearly Profit, Operating, Gross MarginsLNTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LNTH is creating value.
The number of shares outstanding for LNTH remains at a similar level compared to 1 year ago.
Compared to 5 years ago, LNTH has more shares outstanding
Compared to 1 year ago, LNTH has an improved debt to assets ratio.
LNTH Yearly Shares OutstandingLNTH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
LNTH Yearly Total Debt VS Total AssetsLNTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 4.82 indicates that LNTH is not in any danger for bankruptcy at the moment.
LNTH's Altman-Z score of 4.82 is fine compared to the rest of the industry. LNTH outperforms 79.46% of its industry peers.
The Debt to FCF ratio of LNTH is 1.19, which is an excellent value as it means it would take LNTH, only 1.19 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.19, LNTH belongs to the top of the industry, outperforming 90.81% of the companies in the same industry.
LNTH has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
LNTH has a Debt to Equity ratio (0.49) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 1.19
Altman-Z 4.82
ROIC/WACC2.24
WACC8.04%
LNTH Yearly LT Debt VS Equity VS FCFLNTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.29 indicates that LNTH has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.29, LNTH is doing good in the industry, outperforming 71.89% of the companies in the same industry.
A Quick Ratio of 4.07 indicates that LNTH has no problem at all paying its short term obligations.
The Quick ratio of LNTH (4.07) is better than 75.68% of its industry peers.
Industry RankSector Rank
Current Ratio 4.29
Quick Ratio 4.07
LNTH Yearly Current Assets VS Current LiabilitesLNTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for LNTH have decreased by -4.77% in the last year.
Measured over the past years, LNTH shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.10% on average per year.
The Revenue has been growing slightly by 5.75% in the past year.
LNTH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.59% yearly.
EPS 1Y (TTM)-4.77%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-12.78%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%-4.07%

3.2 Future

The Earnings Per Share is expected to grow by 4.53% on average over the next years.
LNTH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.78% yearly.
EPS Next Y-14.1%
EPS Next 2Y-5.8%
EPS Next 3Y1.61%
EPS Next 5Y4.53%
Revenue Next Year-2.39%
Revenue Next 2Y0.39%
Revenue Next 3Y4.41%
Revenue Next 5Y6.78%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LNTH Yearly Revenue VS EstimatesLNTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
LNTH Yearly EPS VS EstimatesLNTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.85, the valuation of LNTH can be described as reasonable.
Based on the Price/Earnings ratio, LNTH is valued cheaper than 95.14% of the companies in the same industry.
LNTH is valuated cheaply when we compare the Price/Earnings ratio to 27.24, which is the current average of the S&P500 Index.
LNTH is valuated reasonably with a Price/Forward Earnings ratio of 9.40.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaper than 92.97% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.81. LNTH is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.85
Fwd PE 9.4
LNTH Price Earnings VS Forward Price EarningsLNTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

96.22% of the companies in the same industry are more expensive than LNTH, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, LNTH is valued cheaply inside the industry as 97.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.03
EV/EBITDA 7.71
LNTH Per share dataLNTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2Y-5.8%
EPS Next 3Y1.61%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LNTH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (8/25/2025, 11:13:04 AM)

56.555

-1.66 (-2.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners116.41%
Inst Owner Change2.48%
Ins Owners1.23%
Ins Owner Change3.71%
Market Cap3.85B
Analysts82.11
Price Target91.96 (62.6%)
Short Float %12.46%
Short Ratio5.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.82%
Min EPS beat(2)-9.67%
Max EPS beat(2)-7.97%
EPS beat(4)2
Avg EPS beat(4)-2.24%
Min EPS beat(4)-9.67%
Max EPS beat(4)7.07%
EPS beat(8)5
Avg EPS beat(8)2.73%
EPS beat(12)9
Avg EPS beat(12)9.01%
EPS beat(16)13
Avg EPS beat(16)19.34%
Revenue beat(2)0
Avg Revenue beat(2)-4.16%
Min Revenue beat(2)-4.74%
Max Revenue beat(2)-3.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-4.74%
Max Revenue beat(4)2.13%
Revenue beat(8)4
Avg Revenue beat(8)0.01%
Revenue beat(12)8
Avg Revenue beat(12)1.39%
Revenue beat(16)12
Avg Revenue beat(16)4.04%
PT rev (1m)-29.74%
PT rev (3m)-33.18%
EPS NQ rev (1m)-21.87%
EPS NQ rev (3m)-23.16%
EPS NY rev (1m)-14.02%
EPS NY rev (3m)-14.64%
Revenue NQ rev (1m)-8.29%
Revenue NQ rev (3m)-10.35%
Revenue NY rev (1m)-5.67%
Revenue NY rev (3m)-5.73%
Valuation
Industry RankSector Rank
PE 8.85
Fwd PE 9.4
P/S 2.53
P/FCF 8.03
P/OCF 7.29
P/B 3.3
P/tB 6.1
EV/EBITDA 7.71
EPS(TTM)6.39
EY11.3%
EPS(NY)6.02
Fwd EY10.64%
FCF(TTM)7.04
FCFY12.45%
OCF(TTM)7.76
OCFY13.72%
SpS22.37
BVpS17.16
TBVpS9.27
PEG (NY)N/A
PEG (5Y)0.21
Profitability
Industry RankSector Rank
ROA 12.81%
ROE 23.23%
ROCE 23.72%
ROIC 18.03%
ROICexc 29.02%
ROICexgc 54.83%
OM 28.64%
PM (TTM) 17.82%
GM 63.75%
FCFM 31.47%
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 1.19
Debt/EBITDA 1.14
Cap/Depr 79.81%
Cap/Sales 3.21%
Interest Coverage 250
Cash Conversion 106.19%
Profit Quality 176.61%
Current Ratio 4.29
Quick Ratio 4.07
Altman-Z 4.82
F-Score5
WACC8.04%
ROIC/WACC2.24
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.77%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-12.78%
EPS Next Y-14.1%
EPS Next 2Y-5.8%
EPS Next 3Y1.61%
EPS Next 5Y4.53%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%-4.07%
Revenue Next Year-2.39%
Revenue Next 2Y0.39%
Revenue Next 3Y4.41%
Revenue Next 5Y6.78%
EBIT growth 1Y-3.87%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year4.08%
EBIT Next 3Y11.88%
EBIT Next 5YN/A
FCF growth 1Y95.83%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y91.73%
OCF growth 3Y116.21%
OCF growth 5Y46.62%